Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
about
Aspirin in the Chemoprevention of Colorectal Neoplasia: An OverviewSingle dose oral sulindac for acute postoperative pain in adultsColorectal cancer chemoprevention: is this the future of colorectal cancer prevention?Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trialsTranslational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaBiomarkers in phase I-II chemoprevention trials: lessons from the NCI experienceMolecular cancer prevention: Current status and future directionsPolyamines and cancer: implications for chemotherapy and chemopreventionNotes from the field: "green" chemoprevention as frugal medicineAt the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancerChemoprevention in familial adenomatous polyposisChemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerNew Insights into the Design of Inhibitors of Human S -Adenosylmethionine Decarboxylase: Studies of Adenine C 8 Substitution in Structural Analogues of S -Adenosylmethionine †The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimismSulindac enhances the killing of cancer cells exposed to oxidative stressDifluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 inductionCombination of sulindac and dichloroacetate kills cancer cells via oxidative damageChemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisEffect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.Spermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine.Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicColorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study.Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trialA systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047.Determination of eflornithine enantiomers in plasma by precolumn derivatization with o-phthalaldehyde-N-acetyl-L-cysteine and liquid chromatography with UV detection.A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice.Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032Epigallocatechin 3-gallate and green tea catechins: United they work, divided they failApigenin Inhibits Human SW620 Cell Growth by Targeting Polyamine Catabolism.Cancer prevention research - then and nowEffects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials.The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationTumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of beta-catenin signaling.Difluoromethylornithine: the proof is in the polyamines.Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylaseCombination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity
P2860
Q22306433-7BAB2362-5555-4290-8668-D055C87FF51FQ24240215-D2B7D337-1E9C-4CFB-963E-DB87BD8808E7Q24620457-3142726C-B64F-4613-A1E7-DF64772B7F02Q26765196-988A8556-5036-46CD-B03B-F35F6214AED1Q26770306-61A49686-4DD9-4ACF-B38F-10848BF9BDE2Q26774585-DA2BCBD6-FED2-47CB-AA09-7E3987563671Q26797207-418DDD5A-074B-42B4-AD73-683A6F410A01Q26864516-F792547E-63A1-435D-8CDB-7C90E7CA5B73Q27021094-C11712DA-062C-4D0E-B997-808EDEC2CF66Q27023485-396B624B-776C-495C-ACCD-EBE4E5464B95Q27023845-FC8F67E3-B71E-491E-B2D9-9E6EC61A7716Q27026428-386B40E5-6B8C-4CBF-97EE-138A78E4B529Q27653732-B408CC5C-C1AF-46B4-A826-42DDCD907C4AQ28087427-3C3B6E72-1A63-429A-B0C5-5B8F895D117EQ28475579-737C4FC4-D74E-4DD7-99AB-1CA500BA6F69Q28477296-ACE4826E-7E8C-4259-BB9A-BE678887799CQ28481378-DF452F71-D4FD-412C-94AA-525DEF0767BCQ28589784-F79AE48F-E433-4948-ADAC-432EC2E861EDQ29619860-71D8873F-7D59-4FD1-A325-5EEE29636359Q30362087-09193DC4-2A03-483D-BF1A-A9A83A529818Q30484125-A5DDC0C2-695A-4C12-B73D-651460233FCFQ30498812-A50114EF-8B89-42CC-B195-B6099C6F1698Q30726318-B92447CB-7DA8-4CCD-A8EE-037F1835F0B8Q31094373-D0EF450A-D41F-4C9D-831A-BEB852F35013Q33517982-BECE1D16-FB3A-402F-9654-726ECB814F12Q33519596-5A5ED6A1-D86E-4460-93B9-C9E7C61DFB64Q33584310-57CD6232-667B-46F0-9A23-F4AA358A1CBAQ33636771-580211A3-221C-4FBD-9052-DB86A9A82F5CQ33642396-B2411C86-336C-4C25-9C69-E29B26AC025BQ33655389-13A50A6C-923B-473D-B403-A5D0BBDBB034Q33720933-9F87EE3E-B768-4DD3-9BC7-8509AAC22F3CQ33726196-C8B3438C-D5B3-434F-948F-986A122A79AEQ33739788-27C5106C-E474-4958-BE19-21EFAEB38B16Q33761692-59081264-8528-4DB4-A08A-45468363EE48Q33823652-C8FD007B-BDA4-4CC0-ACF9-6AAD42887EE3Q33859016-F0BD4A3E-A431-487A-9E26-7EC64120E119Q33883491-AF3BA8F5-3EC0-474B-AC6F-9A7AFBAD009DQ33895607-038A1F18-3FB0-4D13-A937-BBC0AC049188Q33911623-46882027-F0B3-49B5-BAA0-38CEBC95DFB0Q33949553-D6E83E55-851E-4B9F-AC87-C31E42A6D344
P2860
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Difluoromethylornithine plus s ...... ontrolled, double-blind trial.
@en
type
label
Difluoromethylornithine plus s ...... ontrolled, double-blind trial.
@en
prefLabel
Difluoromethylornithine plus s ...... ontrolled, double-blind trial.
@en
P2093
P2860
P1476
Difluoromethylornithine plus s ...... ontrolled, double-blind trial.
@en
P2093
C Gregory Albers
Christine E McLaren
Curt H Hagedorn
D Kim Turgeon
Daniel L Gillen
Daniel Pelot
Dennis J Ahnen
Ernest Hawk
Eugene W Gerner
Frank L Meyskens
P2860
P356
10.1158/1940-6207.CAPR-08-0042
P577
2008-06-01T00:00:00Z